METHODS OF VIBRATIONALLY EXCITING A LARYNGEAL NERVE
20220378650 · 2022-12-01
Inventors
- Alex Jolly (Newport Beach, CA, US)
- Cameron Jolly (Newport, CA, US)
- Kristin King (Littleton, NC, US)
- Jose Comino (Irvine, CA, US)
- Daniel Carrillo (Irvine, CA, US)
- Wayne Fong (Irvine, CA, US)
- Kenneth Green (La Habra Heights, CA, US)
Cpc classification
A61H1/00
HUMAN NECESSITIES
A61H2201/501
HUMAN NECESSITIES
International classification
Abstract
A laryngeal nerve exciting system includes a collar holding a bridge, or a neckband, pressing soft tissue nerve exciters against a patient's neck providing a source of vibrations to stimulate the laryngeal nerve through the larynx. At least one exciter, and preferably two exciters, provide vibrations at preferably 70 Hz to 11 OHz and sufficiently strong to penetrate to the laryngeal nerve. The exciters may be held by the collar circling the neck, or by the neck band partially circling the neck. The therapy system includes a Personal Digital Assistant (PDA) and software which wirelessly connects, monitors, and triggers the device. The system may be used to treat dysphagia, chronic cough, and spasmodic dysphonia.
Claims
1. A method of vibrationally exciting a laryngeal nerve to treat at least one of a swallow disorder, a voice disorder, or chronic cough, the method comprising: providing a laryngeal nerve exciter system comprising: a neckband, the neckband comprising a first free end and a second free end opposing each other to form an open front, the neckband being flexible to accommodate necks of different sizes, a first transducer extending from the first free end of the neckband, the first transducer comprising a first surface coupled to the first free end of the neckband and a second surface opposing the first surface, a second transducer extending from the second free end of the neckband, the second transducer comprising a first surface coupled to the second free end of the neckband and a second surface opposing the first surface of the second transducer, a first nerve effector operatively coupled to the first transducer, the first nerve effector comprising a first end coupled to the second surface of the first transducer and a second end opposing the first end, and a second nerve effector operatively coupled to the second transducer, the second nerve effector comprising a first end coupled to the second surface of the second transducer and a second end opposing the first end of the second nerve effector; coupling first and second adhesive pads respectively to the first and second nerve effectors, each of the first and second adhesive pads comprising a first surface coupled to the second end of the first or second nerve effector and a second surface opposing the first surface of each adhesive pad, the second surfaces of the first and second adhesive pads being adhesive; placing the neckband at least partially around a neck of a patient; moving the neckband such that the first and second adhesive pads are respectively positioned against first and second portions of the patient's neck different from each other and the open front of the neckband exposes the patient's throat and the second surfaces of the first and second adhesive pads fix positions of the neckband by adhering to the skin of the patient; vibrationally exciting the laryngeal nerve of the patient to treat at least one of a swallow disorder, a voice disorder, or chronic cough, the vibrationally exciting including generating vibration, by the first and second transducers, and conducting, by the first and second nerve effectors, the generated vibration to the patient's neck; measuring, by first and second force sensors, force of the first and second nerve effectors against the first and second portions of the patient's neck; and generating an alarm in response the measured force exceeding a threshold.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] The above and other aspects, features and advantages of the present invention will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings.
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
[0018]
[0019]
[0020]
[0021]
[0022] Corresponding reference characters indicate corresponding components throughout the several views of the drawings.
DETAILED DESCRIPTION
[0023] The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing one or more preferred embodiments of the invention. The scope of the invention should be determined with reference to the claims.
[0024] Where the terms “about” or “generally” are associated with an element of the invention, it is intended to describe a feature's appearance to the human eye or human perception, and not a precise measurement.
[0025] A front view of a laryngeal nerve exciter 10 according to the present invention is shown in
[0026] The end effector 18 of the laryngeal nerve exciter 10 is shown in
[0027] A top view of a second embodiment of a laryngeal nerve exciter 30 is shown in
[0028]
[0029]
[0030]
[0031]
[0032] A laryngeal nerve exciter system 60 is shown in
[0033] The PDA 64 may communicate with a secure server 68 through the Internet or any other suitable connection including wireless or wired connections 66 providing signals include frequency, intensity, therapy time, vibration time, duration of rest period between vibration, clinician calibration, and allows for patients to provide feedback about the therapy.
[0034] The secure server 68 may communicate with a work station 72 over the Internet or any other suitable connection including wireless or wired connections 70 providing signals include frequency, intensity, therapy time, vibration time, duration of rest period between vibration, and clinician calibration, and allows for patients to provide feedback about the therapy to the clinician.
[0035] The App may set the frequency of the neckband trainer 42, intensity, therapy time, vibration time, duration of rest period between vibration, and allows for patients to provide feedback about the therapy. Measurements made by the neckband trainer 42 (e.g., force measured by the exciters) may be provided to the PDA 46 via the Bluetooth® connection. Further, the system 60 may allow clinicians to monitor the patient's progress. The clinician will be able to see the device settings, frequency of the device, intensity, therapy time, vibration time, duration of rest period between vibration, number of uses, whether therapy was completed, and the patient feedback. A general state of health section for the patient may be provided to indicate how the patient is feeling before and after the therapy. The PDA 64 may be a smart phone.
[0036] While the invention herein disclosed has been described by means of specific embodiments and applications thereof, numerous modifications and variations could be made thereto by those skilled in the art without departing from the scope of the invention set forth in the claims.